Trademarkia Logo

Canada

C$
Trademark Search in Canada
BEIGENE (& DESIGN)

View On IC.GC.CA

BEIGENE (& DESIGN)
REGISTERED

on 20 Aug 2019

Last Applicant/ Owned by

BEIGENE LTD. C/O MOURANT OZANNES CORPORATE SERVICES (CAYMAN) LIMITED A LEGAL ENTITY

94 Solaris Avenue, Camana BayGrand Cayman KY1-1108

KY

Serial Number

1770587 filed on 3rd Mar 2016

Registration Number

TMA1050100 registered on 20th Aug 2019

Registration expiry Date

20th Aug 2029

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

BEIGENE (& DESIGN)

Trademark usage description

medicines for human purposes, namely pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, c Read More

Vienna Information

26 . 4 . 1

SquaresCarrés

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 22

Quadrilaterals containing other inscriptionsQuadrilatères contenant d'autres inscriptions

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

28 . 3 . 0

Inscriptions in Chinese, Japanese or Korean charactersInscriptions en caractères chinois, japonais ou coréens

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 8

BlackNoir

Classification Information

Class [005]
Medicines for human purposes, namely pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer, autoimmune and inflammatory diseases, namely inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis, glomerulonephritis and lung fibrosis, psoriasis, hypersensitivity reactions of the skin, atherosclerosis, restenosis, allergic asthma, multiple sclerosis, systemic lupus erythematosus, scleroderma, mixed connective tissue disease, polyarteritis nodosa, polymyositis and dermatomyositis, Sjogren's syndrome, Bechet's disease, autoimmune diabetes, Hashimoto's disease, primary myxedema, pernicious anemia, myasthenia gravis, chronic active hepatitis, autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura, uveitis, vasculitides and heparin induced thrombocytopenia, and infectious diseases, namely HIV, and HCV; diagnostic biomarker reagents for medical purposes, namely radio-isotope markers for diagnostic use, diagnostic reagents for medical diagnostic use.

Classification kind code

10

Class [035]
Retail or wholesale services for pharmaceutical preparations and medical supplies, namely catheters, infusion pumps, blood transfusion sets, blood transfusion apparatus, blood filters, syringes for medical purposes, subcutaneous valves for implantation, apparatus for taking blood, apparatus for blood analysis, blood pressure monitors.

Classification kind code

10

Class [040]
Services in the field of chemical processing and transformation of inorganic and organic substances, namely of small molecular drugs and antibodies.

Classification kind code

10

Class [042]
Technical research, namely biomedical research services; technical project studies, namely conducting feasibility studies; research and development of new products for others, namely pharmaceutical research and development; chemical analysis; chemistry services, namely chemical research; clinical trials; biological research.

Classification kind code

10

Class [044]
Pharmacy advice; telemedicine services; health counseling, namely nutrition counseling, drug rehabilitation counseling services.

Classification kind code

10

Mark Details

Serial Number

1770587

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 27th Jul 2018		Allowed
Submitted for opposition 42
on 11th Apr 2018		Advertised
Submitted for opposition 26
on 22nd Mar 2018		Approved
Submitted for opposition 27
on 1st Feb 2018		Approval Notice Sent
Submitted for opposition 15
on 26th Jul 2017		Correspondence Created
Submitted for opposition 22
on 24th Nov 2016		Search Recorded
Submitted for opposition 20
on 24th Nov 2016		Examiner's First Report
Submitted for opposition 31
on 7th Mar 2016		Formalized
Submitted for opposition 30
on 3rd Mar 2016		Filed
Submitted for opposition 1
on 3rd Mar 2016		Created